Figures computed from official regulatory filings — .
Analysttarget 7 USD (+838%) · consensus 5/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 55.2% · institutions 0.13% · short 1.0% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for PetVivo Holdings, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. The company is based in Edina, Minnesota.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
284 buys5 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Rudelius Robert Jamestrack record | Award | $1.4K | SEC |
| Rudelius Robert Jamestrack record | Award | $1.1K | SEC |
| A.L. Sarroff Fund, LLCtrack record | Buy | $15K | conv 29 | SEC |
| A.L. Sarroff Fund, LLCtrack record | Buy | $17.1K | conv 29 | SEC |
| A.L. Sarroff Fund, LLCtrack record | Buy | $7.4K | conv 29 | SEC |
| A.L. Sarroff Fund, LLCtrack record | Buy | $398.5 | conv 31 | SEC |
| Lai Johntrack record | Award | $25K | SEC |
| LOWENTHAL GARRY N | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| LOWENTHAL GARRY N | Award | $25K | SEC |
| Lai Johntrack record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| LOWENTHAL GARRY N | Award | $25K | SEC |
| LOWENTHAL GARRY N | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Lai Johntrack record | Award | $57.8K | SEC |
| LOWENTHAL GARRY N | Award | $57.8K | SEC |
| A.L. Sarroff Fund, LLCtrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| A.L. Sarroff Fund, LLCtrack record | Buy | n/a (No price was disclosed in the filing) | conv 38 | SEC |
| A.L. Sarroff Fund, LLCtrack record | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| A.L. Sarroff Fund, LLCtrack record | Buy | $100K | conv 43Unusual size | SEC |
| LOWENTHAL GARRY N | Award | $47.8K | SEC |
| Lai Johntrack record | Award | $47.8K | SEC |
| Rudelius Robert Jamestrack record | Award | $20K | SEC |
| A.L. Sarroff Fund, LLCtrack record | Buy | $15.7K | conv 30 | SEC |
| A.L. Sarroff Fund, LLCtrack record | Buy | $750 | conv 29 | SEC |
| Ruben Joshua David | Award | $5.6K | SEC |
| Ruben Joshua David | Award | $34.3K | SEC |